Technology

Significant Movers: JD.com, Inc. (NASDAQ:JD), Medidata Solutions, Inc. (NASDAQ:MDSO)

0 1

JD.com, Inc. (NASDAQ:JD) went higher by +1.07% to close at $ 22.66. The company exchanged total volume of 12.08 million shares throughout course of last trade however it holds an average trading capacity of 16.77 million shares. Shares of company began trading at $22.52 climbed to high of $22.90 touched the low of $22.32.

The company is trading above its 50-day moving averages of 21.42 and down from 200-day moving averages of 24.84. The firm has price to book ratio of 6.90 and its price to sale ratio was 1.04.

The average true range of JD.com, Inc.’s (JD) is recorded at 0.74 and the relative strength index of the stock stands 59.30. The stock price is going above to its 52 week low with 16.15% and lagging behind from its 52 week high with -36.28%. Analyst recommendation for this stock stands at 2.00. A look on the firm performance, its monthly performance is 7.60% and a quarterly performance of -20.99%. The stock price is trading downbeat from its 200 days moving average with -13.93% and up from 50 days moving average with 2.87%.

Brokerage Recommendations:

According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. One week ago, shares have been suggested as “BUY” from “3” brokerage firms and recommended as “Strong Buy” by “1” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “1.81” brokerage firms. “0” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 0 based on consensus of the brokerage firms issuing ratings.

Medidata Solutions, Inc. (NASDAQ:MDSO) surged +14.66% and closed the trade at $ 53.58. The company recorded a trading capacity of 2.09 million shares above its three months average daily volume of 401.68 thousand shares. During the last trade, shares reached to high price of $54.24 and touched the low price of $47.24. The stock’s 50-day moving average is noted at $46.70 and its 200-day moving average is stands at $41.92.

Additionally, the company has a PE ratio of 164.36 and has EPS of 0.33. The company has market capitalization of $2.96B.

Medidata (MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, recently reported its financial results for the q2 of 2016.

“Our q2 results come from strong execution across the Firmand reflect Medidata’s momentum in driving adoption of our integrated cloud platform,” stated Tarek Sherif, Medidata’s chairman and chief executive officer. “With demand growing for Medidata CTMS, Payments, Balance and mHealth, as well as data analytics, we’re building on the success of the broadest platform in the industry, while continually delivering greater value to our clients. Recently, over ever, our ability to generate sustainable, long-term growth is driven by the large prospects created by our clients’ innovation, scientific advances and our mission of powering smarter treatments to improve healthcare. It’s clear that Medidata is becoming the planned technology partner to a massive and important transformation in life sciences and healthcare driven by digital automation in drug development.”

Medidata Solutions, Inc.’s (MDSO) has price-to-cash ratio of 9.59 and price to sale ratio of 7.67. The company net profit margin is 4.70% and gross profit margin is 77.20%. A look on the firm performance, its monthly performance is 16.43% and a quarterly performance of 28.98%. The stock price is moving up from its 20 days moving average with 14.78% and isolated positively from 50 days moving average with 17.99%.

Brokerage Recommendations:

According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. One week ago, shares have been suggested as “BUY” from “1” brokerage firms and recommended as “Strong Buy” by “2” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “1.65” brokerage firms. “1” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 0 based on consensus of the brokerage firms issuing ratings.

 

 

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

Advirtisement

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter